FDA Inspection
Michael A. Allon, MPPAMichael A. Allon, MPPA – FDA Inspection, Mar 2, 2018
Record Details
This FDA Inspection record concerns Michael A. Allon, MPPA, with an inspection on March 2, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · aecfc711-d0f6-4dfb-851c-763075a7ec04
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1043404
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Michael A. Allon, MPPA
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 1, 2026 | Not classified | Dallas District Office | Human Cellular, Tissue, and Gene Therapies |
| November 4, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 31, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 8, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 28, 2011 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Michael A. Allon, MPPA
- FDA Inspection 1319906 - 2026-06-01
- FDA Inspection 1191016 - 2022-11-04
- FDA Inspection 972437 - 2016-05-31
- FDA Inspection 855107 - 2013-11-08
- FDA Inspection 761205 - 2011-12-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.